Two digital health start-ups are on the rise: Indivi has secured the Infosys Innovation Fund as a strategic investor, and Aepsy has acquired Kinastic to accelerate its growth. Bewe Lab also operates ...

Since Logmind latest funding round in 2025, the EPFL spinoff led by Ketevani Zaridze has come a long way, working with organizations across different industries but also hiring a Chief Commercial ...

Indivi is a Basel-based TechBio company advancing precision neuroscience to accelerate the development of novel therapeutics. Neurodegenerative disease trials suffer high failure ...

ProSeed, founded in Sion in 2023 out of HES-SO Valais, converts wet by-products from food processing into dry, food-grade ingredients. Its current inputs are brewer's spent grain and oat okara, and it ...

Following a staged ramp-up since January, Vattenfall now has the full 55 MW from the seven-year tolling contract available in live operation. Via its LAYR flexibility platform, terralayr aggregates ...

Geneva-based Spineart and Vaud-based Distalmotion have each cleared a new regulatory hurdle for their surgical technologies. Spineart has received U.S. Food and Drug Administration (FDA) approval for ...

Dyneo Technologies is on a roll. As CEO and Co-founder Maël Perret explains to Startupticker.ch, the company’s traction has accelerated markedly over the past twelve months. Dyneo works with leading ...

The shareholders of Swiss sovereign cloud provider Infomaniak have signed an agreement for the listing of the company on the SIX Swiss Exchange, through a reverse takeover transaction with Perrot ...

FGE NexantECA has completed the acquisition of Morges-based Square Commodities ("SquareCo"), the leading research and data analytics platform specialising in the global renewable fuels market. Founded ...

Zug-based startup AVEA develops science-backed longevity solutions based on the latest scientific research. The company has now brought Olympic gold medallist and two-time halfpipe world champion ...

Oculis is a biopharmaceutical company focused on neuro-ophthalmology and ophthalmology. Its late-stage clinical pipeline focuses on two core product candidates. Privosegtor and Licaminlimab.

Atinary intends to integrate Chemspeed configurable laboratory automation platforms, Bruker analytical instruments and SciY scientific software into its agentic AI workflows. Bruker acquired ...